NYSE American - Delayed Quote USD

Stereotaxis, Inc. (STXS)

2.5600 +0.0600 (+2.40%)
At close: April 23 at 4:00 PM EDT
2.6000 +0.04 (+1.56%)
After hours: April 23 at 6:23 PM EDT
Loading Chart for STXS
DELL
  • Previous Close 2.5000
  • Open 2.5300
  • Bid --
  • Ask --
  • Day's Range 2.5300 - 2.6650
  • 52 Week Range 1.3300 - 3.2900
  • Volume 235,404
  • Avg. Volume 309,156
  • Market Cap (intraday) 210.25M
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2700
  • Earnings Date May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.60

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

www.stereotaxis.com

122

Full Time Employees

December 31

Fiscal Year Ends

Recent News: STXS

Performance Overview: STXS

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

STXS
46.29%
S&P 500
6.30%

1-Year Return

STXS
43.82%
S&P 500
22.67%

3-Year Return

STXS
66.75%
S&P 500
22.63%

5-Year Return

STXS
31.28%
S&P 500
74.37%

Compare To: STXS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: STXS

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    210.25M

  • Enterprise Value

    201.50M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.72

  • Price/Book (mrq)

    12.86

  • Enterprise Value/Revenue

    7.53

  • Enterprise Value/EBITDA

    -9.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -77.37%

  • Return on Assets (ttm)

    -28.64%

  • Return on Equity (ttm)

    -76.93%

  • Revenue (ttm)

    26.77M

  • Net Income Avi to Common (ttm)

    -22.06M

  • Diluted EPS (ttm)

    -0.2700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.82M

  • Total Debt/Equity (mrq)

    25.05%

  • Levered Free Cash Flow (ttm)

    -2.53M

Research Analysis: STXS

Analyst Price Targets

4.00
4.60 Average
2.5600 Current
5.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: STXS

Fair Value

2.5600 Current
 

Dividend Score

0 Low
STXS
Sector Avg.
100 High
 

Hiring Score

0 Low
STXS
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
STXS
Sector Avg.
100 High
 

People Also Watch